(Q52973188)

10 May 2018

title

Molecular mechanism of interferon alfa-mediated growth inhibition in human neuroendocrine tumor cells. (English)

1 reference

10 May 2018

1 reference

Detjen KM

1

1 reference

10 May 2018

Welzel M

2

1 reference

10 May 2018

Farwig K

3

1 reference

10 May 2018

Brembeck FH

4

1 reference

10 May 2018

Kaiser A

5

1 reference

10 May 2018

Riecken EO

6

1 reference

10 May 2018

Wiedenmann B

7

1 reference

10 May 2018

Rosewicz S

8

1 reference

10 May 2018

language of work or name

English

0 references

publication date

1 April 2000

1 reference

10 May 2018

published in

Gastroenterology

1 reference

10 May 2018

volume

118

1 reference

10 May 2018

issue

4

1 reference

10 May 2018

page(s)

735-748

1 reference

10 May 2018

Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Control of growth in neuroendocrine gastro-enteropancreatic tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Drug therapy in metastatic neuroendocrine tumors of the gastroenteropancreatic system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Interferon-alpha versus somatostatin or the combination of both in gastro-enteropancreatic tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

How does interferon exert its cell growth inhibitory effect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

The growing family of interferon regulatory factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Differential myeloma cell responsiveness to interferon-alpha correlates with differential induction of p19(INK4d) and cyclin D2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

A role for the cyclin-dependent kinase inhibitor p21 in the G1 cell cycle arrest mediated by the type I interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Double-stranded RNA-dependent protein kinase mediates c-Myc suppression induced by type I interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Gastrin and phorbol 12-myristate 13-acetate regulate the human histidine decarboxylase promoter through Raf-dependent activation of extracellular signal-regulated kinase-related signaling pathways in gastric cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Antiproliferative effects of interferon alpha on human pancreatic carcinoma cell lines are associated with differential regulation of protein kinase C isoenzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Mutations in the MEN I gene in sporadic neuroendocrine tumours of gastroenteropancreatic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Interferon-mediated activation of the STAT signaling pathway in a human carcinoid tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Expression of p68 protein kinase and its prognostic significance during IFN-alpha therapy in patients with carcinoid tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Differential expression of the p27Kip1 mRNA in IFN-sensitive and resistant cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Cell cycle regulation of the double stranded RNA activated protein kinase, PKR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Analysis of multiple molecular changes in human endocrine tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Block of a glioma cell line in S by interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Relationship between the enhanced expression of histocompatibility antigens on interferon-treated L 1210 cells and their position in the cell cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Interferon potentiates antiproliferative activity of CPT-11 against human colon cancer xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Interferon-beta induces S phase accumulation selectively in human transformed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Modulation of E2F activity is linked to interferon-induced growth suppression of hematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Cell cycle-dependent usage of transcriptional start sites. A novel mechanism for regulation of cyclin B1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

Promoter binding factors regulating cyclin B transcription in the sea urchin embryo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970143-0

10.1016/S0016-5085(00)70143-0

7 January 2021

Identifiers

DOI

1 reference

10 May 2018

1 reference

10 May 2018